Analysis of length of stay and treatment emergent complications in hospitalized myasthenia gravis patients with exacerbation.

ABSTRACT:

Introduction

AIMS Myasthenia Gravis (MG) is an autoimmune neuromuscular disease in which patients suffer from recurrent exacerbation. There are insufficient data measuring the effects of the resources employed before and during acute exacerbation on subsequent disease outcomes. This study aims to identify factors which lead to lengthened hospital stay.

Methods

This is a retrospective chart review of acute MG exacerbations requiring hospitalization. Exacerbations were identified using ICD-9/ICD-10 codes and considered the following variables: age and Myasthenia Gravis Foundation of America (MGFA) class at initial MG diagnosis, age and MGFA class at exacerbation, sex, thymectomy, cause of exacerbation, treatment regimen at time of exacerbation, inpatient treatment regimen, len

SUBMITTER: Ramsaroop T 

PROVIDER: S-EPMC9835387 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature